Page last updated: 2024-08-16

sotalol and penbutolol

sotalol has been researched along with penbutolol in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (60.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Desager, JP; Harvengt, C; Heller, F; Hulhoven, R	1
Johansson, SR; McCall, M; Vedin, JA; Wilhelmsson, C	1
Merkle, W	1

Reviews

1 review(s) available for sotalol and penbutolol

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

2 trial(s) available for sotalol and penbutolol

Article	Year
Duration of action of beta blockers. Clinical pharmacology and therapeutics, 1980, Volume: 27, Issue:5 Topics: Adrenergic beta-Antagonists; Adult; Alprenolol; Atenolol; Blood Pressure; Coronary Disease; Heart Rate; Humans; Metoprolol; Penbutolol; Physical Exertion; Pindolol; Propranolol; Regression Analysis; Rest; Sotalol; Time Factors; Timolol	1980
[Results with new beta receptor blockaders in the therapy of glaucoma]. Fortschritte der Ophthalmologie : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 1983, Volume: 79, Issue:5 Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Glaucoma; Humans; Levobunolol; Metipranolol; Penbutolol; Propranolol; Random Allocation; Sotalol	1983

Other Studies

2 other study(ies) available for sotalol and penbutolol

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Beta-blocking agents and plasma lipids: an update. Advances in experimental medicine and biology, 1987, Volume: 210 Topics: 1-Propanol; Adrenergic beta-Antagonists; Atenolol; Cholesterol, LDL; Coronary Disease; Humans; Hypertension; Lipids; Lipoproteins, HDL; Lipoproteins, HDL2; Lipoproteins, LDL; Oxprenolol; Penbutolol; Pindolol; Sotalol	1987

Article

Year

Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.

Current drug discovery technologies, 2004, Volume: 1, Issue:4

Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004

Beta-blocking agents and plasma lipids: an update.

Advances in experimental medicine and biology, 1987, Volume: 210

Topics: 1-Propanol; Adrenergic beta-Antagonists; Atenolol; Cholesterol, LDL; Coronary Disease; Humans; Hypertension; Lipids; Lipoproteins, HDL; Lipoproteins, HDL2; Lipoproteins, LDL; Oxprenolol; Penbutolol; Pindolol; Sotalol

1987